5 Results

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Chandarlapaty
    Chandarlapaty
  4. Sawai
    Sawai
  5. Ye
    Ye
  6. Baumgartner
    Baumgartner
  7. Benezra
    Benezra
  8. Benezra
    Benezra
  9. Cartegni
    Cartegni
  10. Chin
    Chin

Groups

  1. Breast Medicine Service (5)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Genitourinary Oncology Service (5)
  5. Human Oncology and Pathogenesis Program (5)
  6. Molecular Pharmacology and Chemistry Program Faculty (5)
  7. Sloan Kettering Institute Faculty (5)
  8. Solid Tumor Oncology Division (5)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  10. Biostatistics Service (1)
  1. "nonhuman"
  2. "Molecular Pharmacology and Chemistry Program Faculty"
  3. "2008"
  4. "David Solit"
Formats
  1. Journal Article (5)
Groups
  1. Breast Medicine Service (5)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Genitourinary Oncology Service (5)
  5. Human Oncology and Pathogenesis Program (5)
  6. Molecular Pharmacology and Chemistry Program Faculty (5)

More Groups

People
  1. David Solit (5)
  2. Neal Rosen (5)
  3. Ayana Sawai (2)
  4. Qing Ye (2)
  5. Sarat Chandarlapaty (2)
  6. Christine Pratilas (1)

More People

Years
  1. 2008 (5)
Publications
  1. Cancer Research (1)
  2. Clinical Cancer Research (1)
  3. Journal of Clinical Endocrinology and Metabolism (1)
  4. Molecular Carcinogenesis (1)
  5. Nature Biotechnology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Nature Publishing Group (1)
  3. Oxford University Press (1)
  4. Wiley Blackwell (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel
    Journal Article

    Sawai, A.; Chandarlapaty, S.; Greulich, H.; Gonen, M.; Ye, Q.; Arteaga, C. L.; Sellers, W.; Rosen, N.; Solit, D. B.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines
    Journal Article

    Leboeuf, R.; Baumgartner, J. E.; Benezra, M.; Malaguarnera, R.; Solit, D.; Pratilas, C. A.; Rosen, N.; Knauf, J. A.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2008)

    Fulltext@MSK | Save
  • Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo
    Journal Article

    Henke, E.; Perk, J.; Vider, J.; De Candia, P.; Chin, Y.; Solit, D. B.; Ponomarev, V.; Cartegni, L.; Manova, K.; Rosen, N.; more...
    Nature Biotechnology (2008)

    Fulltext@MSK | Save
  • SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase - Dependent cancers
    Journal Article

    Chandarlapaty, S.; Sawai, A.; Ye, Q.; Scott, A.; Silinski, M.; Huang, K.; Fadden, P.; Partdrige, J.; Hall, S.; Steed, P.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The 20th Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy 2005
    Journal Article

    Bishop, J. M.; Hanahan, D.; Tlsty, T.; Hunter, T.; Lowe, S.; Varmus, H.; Dornbush, K. T.; Waring, J. F.; Jacks, T.; Gilmer, T.; more...
    Molecular Carcinogenesis (2008)

    Fulltext@MSK | Save